Sodium Citrate and Citric Acid

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Sodium Citrate and Citric Acid
Generic name: SODIUM CITRATE AND CITRIC ACID
Manufacturer: Chartwell RX, LLC
Product type: HUMAN PRESCRIPTION DRUG
SPL set ID: 525136c9-7758-437b-b57b-94b905786825
SPL ID: 19c45cf2-8b45-3d39-e063-6394a90a6e54
Version: 3
Effective date: 2024-05-31
Source export date: 2026-10-12
Source partition: 6
Source file: https://download.open.fda.gov/drug/label/drug-label-0006-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-12/b25dad4aaef9c88f0e827394a34fbbd1ce7d71422fa46b5d1e123befad498c1d/drug-label-0006-of-0014.json.zip
Source manifest SHA-256: 7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run: 20261013T011858Z
Imported at: 2026-10-13 01:46:57

Harmonized routes table
Harmonized routes
ORAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 21 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
brand name		Sodium Citrate and Citric Acid	openfda.brand_name
generic name		SODIUM CITRATE AND CITRIC ACID	openfda.generic_name
manufacturer name		Chartwell RX, LLC	openfda.manufacturer_name
ndc	package	62135-868-24	openfda.package_ndc
ndc	package	62135-868-51	openfda.package_ndc
ndc	package	62135-434-47	openfda.package_ndc
ndc	package	62135-869-43	openfda.package_ndc
ndc	package	62135-869-24	openfda.package_ndc
ndc	product	62135-869	openfda.product_ndc
ndc	product	62135-868	openfda.product_ndc
ndc	product	62135-434	openfda.product_ndc
ndc11	package	62135043447	derived:openfda.package_ndc
ndc11	package	62135086851	derived:openfda.package_ndc
ndc11	package	62135086924	derived:openfda.package_ndc
ndc11	package	62135086943	derived:openfda.package_ndc
ndc11	package	62135086824	derived:openfda.package_ndc
rxcui		543014	openfda.rxcui
spl id		19c45cf2-8b45-3d39-e063-6394a90a6e54	id
spl set id		525136c9-7758-437b-b57b-94b905786825	set_id
unii		2968PHW8QP	openfda.unii
unii		1Q73Q2JULR	openfda.unii

Adverse reactions cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Adverse reactions sections page 1 of 1 · 1 matching rows.

adverse reactions

ADVERSE REACTIONS Sodium citrate and citric acid oral solution is generally well tolerated, without any unpleasant side effects, when given in recommended doses to patients with normal renal function and urinary output. However, as with any alkalinizing agent, caution must be used in certain patients with abnormal renal mechanisms to avoid development of alkalosis, especially in the presence of hypocalcemia.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.